Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosis

BACKGROUND: Over a dozen disease-modifying therapies (DMTs) have been approved for treatment of multiple sclerosis (MS). Treatment guidelines focus on when to initiate, change, and discontinue treatment but provide little guidance on how to select or sequence DMTs. This study assessed sequencing pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Fox, Robert J., Mehta, Rina, Pham, Timothy, Park, Julie, Wilson, Kathleen, Bonafede, Machaon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172015/
https://www.ncbi.nlm.nih.gov/pubmed/35672686
http://dx.doi.org/10.1186/s12883-022-02738-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172015/
https://www.ncbi.nlm.nih.gov/pubmed/35672686
http://dx.doi.org/10.1186/s12883-022-02738-7

Ejemplares similares